Friday, 25 May 2012

Male contraception gene

Just today BBC News published an article on a study which found a gene in mice that could act as a contraceptive, if applied to humans it could lead to an alternative to condoms or vasectomies by causing temporary infertility.

The researchers from Edinburgh randomly altered the genetic code of a group of mice and found that some of them became infertile, they then discovered the gene called Katnal1 which results in healthy sperm development. However when Katnal1 is modified the sperm do not fully form since it contains the blueprints for a protein which is important in cells that support the development if sperm.

Because the gene is responsible for sperm in the late stage of development a drug that interrupted it's action would not leave lasting effects such as permanent infertility.

Dr. Lee Smith, one of the researchers, said it was important to make a non-hormonal contraceptive for men but it would be difficult as the protein lives inside cells, however he went on to say that there may be something else that this protein works with which may be a more vulnerable target.

Either way any non-hormonal drug that acts as a contraceptive for men must be very specific for either the sperm or other cells in the testes involved in sperm production, otherwise it could cause damage to other tissues in the body and may potentially be dangerous.

Jack

Friday, 18 May 2012

Universal Blood Compatibility

For the last part of the human biology course we've been learning about blood transfusions and why some people can safely receive any type of blood and some can only receive blood that exactly matches their own.

People with certain blood types have antibodies in their blood that will attack certain types of donated blood cells by binding to the antigens on their surfaces and causing them to agglutinate, or clump together. Whether or not this happens depends on whether the antibodies in the recipient's blood match the antigens on the cells of the donor's blood, both of which are determined by their blood types.

If the wrong type of blood is given to a patient it could have severe consequences so it is very important that there is always a variety of different types stored at hospitals so a patient of any type can receive a transfusion.

However in 2007 an experiment was carried out in which one blood group was turned into another by removing the antigens. The scientists involved removed the antigens on the erythrocytes using an enzyme which they found after a search of 2,500 different types of bacteria and fungi.

Blood group O which they made has no antigens on its surface so the antibodies in the recipient's blood will not attack it and it will be safe to transfuse. This could go some way to helping the current shortage of blood as it will no longer matter if there is not enough of a particular type; they can simply convert it all into group O and then give that to any patient who needs it. Usually the medical staff try to match the blood group exactly just in case but having an extra supply of O type will mean there is always a backup if an exact match cannot be made.

Jack

Thursday, 10 May 2012

Cancer shield for body cells

The early results of a US trial have shown that it may be possible to protect the body from the damaging effects of chemotherapy, which attacks normal body cells as well as cancerous ones. The chemicals used in the treatment attack rapidly dividing cells so they focus mainly on the cancer but can also attack other cells such as the bone marrow which are very susceptible to chemotherapy as they divide rapidly into blood cells.

A study in Science Translational Medicine used genetically modified stem cells to protect the bone marrow from damage, which is a huge achievement as they are needed to make new blood cells. If however the bone marrow is damaged then fewer white blood cells will lead to a higher risk of infection and fewer red blood cells will cause tiredness and shortness of breath.

The scientists removed stem cells from the bone marrow of three brain cancer patients and "infected" them with a gene that made them more resistant to chemotherapy, before putting them back into the patient so they could continue to produce blood cells.

Protecting the bone marrow from the harmful side effects of chemotherapy will mean that the treatment can be used more fully as sometimes it has to be stopped, delayed or reduced because of the damage being done. The results of the study are promising as the patients survived for longer than the average survival time of 12 months, including one who was still alive 34 months after the treatment.

Jack

Friday, 4 May 2012

Eye implant restores vision

In the past few days you may have heard the news story about the two men who received retina implants which partially restored their vision after more than a decade of inactivity.

The 3mm microelectronic chip with 1,500 light-sensitive pixels was inserted behind the retinas of Chris James and Robin Millar and has altered their lives. It sends flashes of light to their brain rather than conventional vision and they can only see in black and white but it is still a huge improvement to their lives and a big step forward in medical science.

The patients have to 'learn' to interpret the signals being sent as electrical impulses along their optic nerve to their brain. Currently they are able to make out shapes at close range which should lead to them being able to recognise people, but their vision could be improved even further as they master the ability to interpret the signals.

A Finnish man who received the same implant in 2010 was able to interpret letters but his only worked in a laboratory setting and was not portable. Hopefully the next step will be to make an improved version that works just as well so the recipients have the ability to read in addition to it being portable

Also scientists could make one that is able to interpret different wavelengths of light, it could then transmit a signal along the optic nerve just like the light-sensitive cells in a fully functioning eye would, and the patient would be able to see in colour.

I think this concept could be a good alternative to stem cell therapy as so far that has only been carried out on people with some residual vision, not those that are completely blind. It also has fewer ethical implications than the use of stem cells but still with good results. I look forward to seeing how things such as this develop in the future and what progress and improvements they are able to make.

Jack